will compounded semaglutide be banned Did the FDA Ban and Tirzepatide? What is the latest update

This triple mechanism of action distinguishes it from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GIP/GLP-1 receptor agonist)

Gynecol Endocrinol 31(3):196201

Therefore, inhibiting the cytokines that induce inflammation could decrease inflammation and its associated effects in our bodies by targeting DPP-4

With those pathways dulled, it makes sense that people taking these medications would have fewer cravings

If our ancestors brains didnt urge them to eat ravenously, whenever an opportunity arose they probably didnt live long enough to pass along their genes